VIKING THERAPEUTICS INC - CALL Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q4 2025

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025, 1 institutional investors reported holding 154,100 shares of VIKING THERAPEUTICS INC - CALL.

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Calls Notional Value	Price (Median)	Investors
2025 Q4				$299,030	$35.18	0
2025 Q3	154,100	$4,049,000	+$2,522,593	$48,286,868	$26.28	1
2025 Q2	57,600	$1,526,400	+$1,526,400	$27,313,990	$26.50	1
2025 Q1				$23,789,870	$24.15	0
2024 Q4				$68,333,816	$40.24	0
2024 Q3				$102,534,376	$63.31	5
2024 Q2				$99,359,464	$53.01	8
2024 Q1				$148,909,600	$82.00	6
2023 Q4				$22,784,025	$18.61	4
2023 Q3				$11,576,199	$11.07	5
2023 Q2				$44,631,618	$16.21	5
2023 Q1				$41,098,730	$16.65	3
2022 Q4				$6,288,780	$9.40	4
2022 Q3				$475,000	$2.72	2
2022 Q2				$823,000	$2.89	2
2022 Q1				$587,000	$2.99	2
2021 Q4				$2,057,000	$4.60	2
2021 Q3				$5,497,000	$6.30	2
2021 Q2				$4,588,000	$5.99	2
2021 Q1				$4,180,000	$319.24	2
2020 Q4				$1,558,000	$284.04	2
2020 Q3				$3,093,000	$293.89	2
2020 Q2				$4,319,000	$363.91	2
2020 Q1				$3,067,000	$236.12	2
2019 Q4				$3,673,000	$800.36	4
2019 Q3				$2,438,000	$686.23	3
2019 Q2				$2,993,000	$829.92	3
2019 Q1	0	$0	-$558	$5,733,000	$993.38	5
2018 Q4	72,500	$555	+$558	$2,505,000	$7.65	3
2018 Q3				$14,071,000	$1739.88	5
2018 Q2				$4,561,000	$948.88	4
2018 Q1				$125,000	$11.67	2